Laboratorio Reig Jofre SA RJF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €2.58
- Day Range
- €2.44–2.56
- 52-Week Range
- €2.15–2.88
- Bid/Ask
- — / —
- Market Cap
- €197.00 Mil
- Volume/Avg
- 45,202 / 9,718
Key Statistics
- Price/Earnings (Normalized)
- 1.16
- Price/Sales
- 0.63
- Dividend Yield (Trailing)
- 1.58%
- Dividend Yield (Forward)
- 1.58%
- Total Yield
- 1.56%
Company Profile
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,316
- Website
- http://www.reigjofre.com
Comparables
Valuation
|
Metric
|
RJF
|
600568
|
600557
|
|---|---|---|---|
Price/Earnings (Normalized) | 1.16 | — | 22.10 |
Price/Book Value | 0.98 | 1.22 | 2.17 |
Price/Sales | 0.63 | 4.75 | 2.35 |
Price/Cash Flow | 6.49 | — | 8.80 |
Price/Earnings
RJF
600568
600557
Financial Strength
|
Metric
|
RJF
|
600568
|
600557
|
|---|---|---|---|
Quick Ratio | 0.76 | 2.96 | 2.19 |
Current Ratio | 1.47 | 4.52 | 2.52 |
Interest Coverage | 15.00 | −47.83 | — |
Quick Ratio
RJF
600568
600557
Profitability
|
Metric
|
RJF
|
600568
|
600557
|
|---|---|---|---|
Return on Assets (Normalized) | 3.73% | −11.11% | 7.20% |
Return on Equity (Normalized) | 6.19% | −14.19% | 9.86% |
Return on Invested Capital (Normalized) | 5.00% | −13.39% | 9.16% |
Return on Assets
RJF
600568
600557
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Pzhvcwjk | Snp | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Vxyxptlrp | Tkkzmmr | $70.8 Bil | |
HLN
| Haleon PLC ADR | Bwqhjdsk | Xphh | $38.2 Bil | |
VTRS
| Viatris Inc | Rptppnmf | Gllfr | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Pbzkvphj | Nqlx | $12.5 Bil | |
CTLT
| Catalent Inc | Fjwmbwkb | Cskfkl | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Dcwcgbzc | Jdtv | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Sgxzsgy | Wys | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jwjvlqsh | Zfjtb | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Dlplgdmsw | Ryjr | $2.9 Bil |